BFG
AZN icon

Bleakley Financial Group’s AstraZeneca AZN Stock Holding History

Bleakley Financial Group’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.6M Buy
66,437
+2,211
+3% +$416K 0.16% 107
2026
Q1 		$12.7M Buy
64,226
+20,521
+47% +$3.96M 0.2% 95
2025
Q4 		$8.04M Buy
43,705
+3,713
+9% +$651K 0.14% 119
2025
Q3 		$6.14M Buy
39,992
+3,086
+8% +$467K 0.14% 134
2025
Q2 		$5.16M Buy
36,906
+2,025
+6% +$284K 0.13% 147
2025
Q1 		$5.13M Buy
34,881
+4,493
+15% +$650K 0.16% 122
2024
Q4 		$3.98M Sell
30,388
-2,600
-8% -$364K 0.12% 146
2024
Q3 		$5.14M Buy
32,988
+1,151
+4% +$186K 0.16% 112
2024
Q2 		$4.97M Buy
31,837
+1,408
+5% +$212K 0.14% 135
2024
Q1 		$4.12M Sell
30,429
-1,871
-6% -$248K 0.12% 168
2023
Q4 		$4.35M Buy
32,300
+2,132
+7% +$277K 0.14% 142
2023
Q3 		$4.09M Sell
30,168
-513
-2% -$70.1K 0.14% 129
2023
Q2 		$4.39M Buy
30,681
+943
+3% +$139K 0.14% 138
2023
Q1 		$4.13M Buy
29,738
+8,987
+43% +$1.21M 0.14% 139
2022
Q4 		$2.81M Buy
+20,751
New +$2.6M 0.1% 189

Other funds holding AZN

EP
Evelyn Partners London $46.9B AUM
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bleakley Financial Group's AZN Position: Q2 2026 in Review

Bleakley Financial Group increased its AstraZeneca (AZN) stake by 3.4% in Q2 2026, buying an estimated $416K and bringing the position to 66,437 shares worth $12.6M. The position accounts for 0.16% of the portfolio, ranked #107.

Bleakley Financial Group first reported a position in AZN in Q4 2022 and has held it in 15 quarters since. The position peaked at $12.7M in Q1 2026. 1,501 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Bleakley Financial Group held 66,437 shares of AstraZeneca worth $12.6M as of Q2 2026.
  • Bleakley Financial Group bought 2,211 AstraZeneca shares in Q2 2026, an estimated $416K.
  • AstraZeneca made up 0.16% of Bleakley Financial Group's portfolio in Q2 2026, its #107 holding.
  • Bleakley Financial Group first reported a position in AstraZeneca in Q4 2022 and has held it in 15 quarters since.
  • Bleakley Financial Group's AstraZeneca position peaked at $12.7M in Q1 2026.
  • 1,501 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Bleakley Financial Group's 13F filing for Q2 2026, filed 5 Aug 2026.